Found: 11
Select item for more details and to access through your institution.
Development and validation of a new method to simultaneously quantify triazoles in plasma spotted on dry sample spot devices and analysed by HPLC-MS.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
A filter-based cross-sectional analysis of an HIV-positive, HAART-treated cohort in rural Burundi: pharmacokinetics, pharmacogenetics and viral load.
- Published in:
- Journal of the International AIDS Society, 2010, v. 13, p. P179, doi. 10.1186/1758-2652-13-S4-P179
- By:
- Publication type:
- Article
A filter-based cross-sectional analysis of an HIV-positive, HAART-treated cohort in rural Burundi: pharmacokinetics, pharmacogenetics and viral load.
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Influence of single-nucleotide polymorphisms on deferasirox C<sub>trough</sub> levels and effectiveness.
- Published in:
- Pharmacogenomics Journal, 2015, v. 15, n. 3, p. 263, doi. 10.1038/tpj.2014.65
- By:
- Publication type:
- Article
Deferasirox AUC efficacy cutoff and role of pharmacogenetics.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Treatment with direct-acting antiviral agents of hepatitis C virus infection in injecting drug users: A prospective study.
- Published in:
- Journal of Viral Hepatitis, 2017, v. 24, n. 10, p. 850, doi. 10.1111/jvh.12711
- By:
- Publication type:
- Article
Antiretroviral concentrations in the presence and absence of valproic acid.
- Published in:
- 2020
- By:
- Publication type:
- journal article
SLC22A2 variants and dolutegravir levels correlate with psychiatric symptoms in persons with HIV.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Successful pharmacogenetics-based optimization of unboosted atazanavir plasma exposure in HIV-positive patients: a randomized, controlled, pilot study (the REYAGEN study).
- Published in:
- 2015
- By:
- Publication type:
- journal article
Role of CYP27 B1+2838 promoter polymorphism in the treatment of chronic hepatitis B HBe Ag negative with PEG-interferon.
- Published in:
- Journal of Viral Hepatitis, 2015, v. 22, n. 3, p. 318, doi. 10.1111/jvh.12288
- By:
- Publication type:
- Article
Significant early higher ribavirin plasma concentrations in patients receiving a triple therapy with pegylated interferon, ribavirin and telaprevir.
- Published in:
- Journal of Viral Hepatitis, 2014, v. 21, n. 4, p. 260, doi. 10.1111/jvh.12170
- By:
- Publication type:
- Article